Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EBV-associated neoplasms: alternative pathogenetic pathways.

Hans Helmut Niller1, Daniel Salamon, Karin Ilg

  • 1Institut for Medical Microbiology and Hygiene, University of Regensburg, Research Centre Landshuter Str. 22, D-93047 Regensburg, Germany. Hans-Helmut.Niller@klinik.uni-regens-burg.de

Medical Hypotheses
|February 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of an LNA-based multiplex RT-qPCR assay for differentiating Betaarterivirus europensis (PRRSV-1), Betaarterivirus americense (PRRSV-2), and the highly pathogenic L8 lineage of PRRSV-2.

Veterinary journal (London, England : 1997)·2026
Same author

Toscana virus infection acquired in Campania, Italy, in a Hungarian traveller: case report with mini-review.

Tropical diseases, travel medicine and vaccines·2026
Same author

Hungary as a source of West Nile virus diversity and spread in Europe: insights from the 2024 transmission season.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Human Hantavirus Infections in Hungary (2018-2025): Epidemiology, Molecular Detection Across Clinical Sample Types, and Phylogenetic Analysis.

Viruses·2026
Same author

Identification of preterm growth-restricted fetuses requiring delivery within 7 days from the TRUFFLE studies.

American journal of obstetrics and gynecology·2026
Same author

[The "golden age" of tumor biology. Georg Klein (1925-2016) and Eva Klein (1925-2025) were born 100 years ago].

Orvosi hetilap·2025
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Epstein-Barr virus (EBV) drives two lymphoma types: malignant Burkitt's Lymphoma (BL) and Hodgkin's Disease (HD), versus benign post-transplant lymphoproliferative disease (PTLD). The oncoprotein c-Myc and EBNA2 protein play distinct roles in their development.

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) is associated with various lymphoproliferative disorders.
  • These disorders range from benign conditions like post-transplant lymphoproliferative disease (PTLD) to malignant lymphomas such as Burkitt's Lymphoma (BL) and Hodgkin's Disease (HD).
  • The distinct pathogenetic pathways leading to these different outcomes are not fully understood.

Purpose of the Study:

  • To propose a classification of EBV-associated lymphomas into two main classes based on distinct pathogenetic mechanisms.
  • To investigate the role of the oncoprotein c-Myc and the viral protein EBNA2 in the oncogenesis of these EBV-associated lymphoproliferative disorders.

Main Methods:

  • Comparative analysis of EBV genome structure and viral protein functions.

Related Experiment Videos

  • Identification of a binding site for c-Myc within the EBV genome.
  • Hypothesizing distinct molecular scenarios for malignant transformation versus benign lymphoproliferation.

    • Main Results:

    • Discovery of a c-Myc binding site in the EBV genome, suggesting a role in malignant transformation.
    • Proposed two distinct pathways for EBV-associated lymphoproliferative disorders.
    • Scenario 1 (Malignant): Requires EBV genome maintenance and c-Myc-mediated anti-apoptotic function for BL and HD development from germinal center B-cells.
    • Scenario 2 (Benign/Malignant): Requires EBNA2 for immortalization and transformation of B-cells, independent of T-cell control, for PTLD.

    Conclusions:

    • EBV-associated lymphomas can be broadly classified into two groups based on distinct pathogenetic pathways.
    • Malignant lymphomas (BL, HD) depend on c-Myc and EBV genome maintenance for oncogenesis.
    • Benign or potentially malignant lymphoproliferations (PTLD) are driven by EBNA2, with malignancy arising from prolonged lack of T-cell control.